Stars Align For AstraZeneca In JUPITER Trial
AstraZeneca halts Crestor study early after cardiovascular morbidity and mortality is reduced in patients with elevated C-reactive protein.
AstraZeneca halts Crestor study early after cardiovascular morbidity and mortality is reduced in patients with elevated C-reactive protein.